Tandem Diabetes Care (TNDM) Free Cash Flow (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Free Cash Flow came in at $4.8 million in Q1 2026, up 122.53% YoY from $2.2 million in Q1 2025, and up 54.19% on a QoQ basis from $3.1 million in Q4 2025.
Tandem Diabetes Care (TNDM) Free Cash Flow (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Free Cash Flow data on file, last reported at $4.8 million in Q1 2026.
- Quarterly Free Cash Flow rose 122.53% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 124.13% YoY) and the FY2025 annual result came in at -$29.7 million, down 218.12% from the prior year.
- Free Cash Flow grew to $4.8 million in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $27.8 million in Q4 2024 to a low of -$27.2 million in Q1 2023.
- A 5-year average of $866823.5 and a median of $3.1 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow plunged 319.97% — and 2024, when it jumped 410.44%.
- Tracing TNDM's Free Cash Flow over 5 years: stood at $5.6 million in 2022, then plunged by 260.52% to -$8.9 million in 2023, then jumped by 410.44% to $27.8 million in 2024, then sank by 88.82% to $3.1 million in 2025, then jumped by 54.19% to $4.8 million in 2026.
- The last three Free Cash Flow figures came in at $4.8 million (Q1 2026), $3.1 million (Q4 2025), and -$3.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 1.06 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.28 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 585.00 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 184.50 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 68.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 511.44 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn | -37.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -37.24 Mn |
| Jun 30, 2026 | -37.24 Mn |
| Mar 31, 2026 | 4.79 Mn |
| Mar 31, 2026 | 4.79 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Dec 31, 2025 | 3.10 Mn |
| Sep 30, 2025 | -3.93 Mn |
| Sep 30, 2025 | -3.93 Mn |
| Jun 30, 2025 | -7.60 Mn |
| Jun 30, 2025 | -7.60 Mn |
| Mar 31, 2025 | -21.24 Mn |
| Mar 31, 2025 | -21.24 Mn |
| Dec 31, 2024 | 27.77 Mn |
| Dec 31, 2024 | 27.77 Mn |
| Sep 30, 2024 | 21.54 Mn |
| Sep 30, 2024 | 21.54 Mn |
| Jun 30, 2024 | -12.98 Mn |
| Jun 30, 2024 | -12.98 Mn |
| Mar 31, 2024 | -11.21 Mn |
| Mar 31, 2024 | -11.21 Mn |